Genetic alterations defining NSCLC subtypes and their therapeutic implications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Genetic alterations defining NSCLC subtypes and their therapeutic implications

Published:2013-11 Issue:2 Volume:82 Page:179-189
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Pikor Larissa A.,Ramnarine Varune R.,Lam Stephen,Lam Wan L.

Funder

Canadian Institutes for Health Research

Canadian Cancer Society

U.S. Department of Defense

NCI Early Detection Research Network

Canary Foundation

Vanier Canada Graduate Scholarship

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference178 articles.

1. Cancer Facts & Figures 2012;Society, A.C.,2012

2. Canadian Cancer Statistics 2012;Statistics, C.C.S.s.S.C.o.C.,2012

3. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

4. Pathology and genetics of tumours of the lung, pleura, thymus and heart;Travis,2004

5. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

Cited by 282 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibroin nanodisruptor with Ferroptosis-Autophagy synergism is potent for lung cancer treatment;International Journal of Pharmaceutics;2024-10

2. Correlation of TNF-α polymorphisms with susceptibility to lung cancer: evidence from a meta-analysis based on 29 studies;BMC Cancer;2024-09-06

3. Patient-derived organoids and mini-PDX for predicting METN375S-mutated lung cancer patient clinical therapeutic response;Heliyon;2024-09

4. Revolutionizing Lung Cancer Treatment: Nanotechnology-Driven Advances in Targeted Drug Delivery and Novel Therapeutic Strategies;Journal of Drug Delivery Science and Technology;2024-09

5. Bioequivalence study of two formulations of afatinib dimaleate tablets in healthy subjects under fasting conditions: A randomized, open-label, single-dose, crossover trial;Int. Journal of Clinical Pharmacology and Therapeutics;2024-08-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3